State Street Corp My Md Pharmaceuticals, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$1.1 - $2.86 $20,350 - $52,910
18,500 Added 18.18%
120,252 $206,000
Q1 2022

May 16, 2022
BUY
$3.34 - $6.05 $67,354 - $122,004
20,166 Added 24.72%
101,752 $474,000
Q3 2021

Nov 15, 2021
BUY
$4.64 - $7.94 $257,626 - $440,852
55,523 Added 213.03%
81,586 $587,000
Q2 2021

Aug 16, 2021
BUY
$3.39 - $6.98 $88,353 - $181,919
26,063 New
26,063 $164,000

Others Institutions Holding MYMD

# of Institutions
2
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About MyMD Pharmaceuticals, Inc.

MYMD Quotes by TradingView
  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email